PFSI
Commercial- Indications
- Respiratory diseases
Company intelligence / Profile preview
Resyca
Enschede, Netherlandsresyca.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Resyca’s proprietary soft mist inhalers and nasal sprays are used in multiple partnered preclinical and clinical-stage programs to enable efficient pulmonary or nose-to-brain drug delivery—including fragile biologics, small molecules, and mRNA therapies. The company’s devices are being used in IND-enabling studies with Silo Pharma for intranasal PTSD therapy SPC‑15. Clinical results depend on the specific pharmaceutical partner program.
The company itself has achieved ISO13485 certification through at least 2028.
- Therapeutic areas
- OtherPulmonologyNeurologyInfectious Diseases
- Modalities
- Device (Soft mist inhaler)Device (Nasal spray)Biologic (as delivery target)Small molecule (as delivery target)mRNA-based drugs (as delivery target)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Silo Pharma Inc. – device development partnership for intranasal CNS therapeutics including SPC–15Recipharm – exclusive license/collaboration agreement to develop soft mist nasal devices for single/combo products including fragile biologics/mRNA/small moleculesStevanato Group – collaboration on primary packaging integration with Alba® syringe platformCyrano Therapeutics – exclusive license agreement involving soft mist nasal spray tech
Beyond the preview
Go deeper on Resyca.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Resyca.